一个ER压力和线粒体亡联合诱导剂,用于增强癌症免疫治疗
Guangzhao Xu1, Shuzhen Chen2, Hekai Yang2
1School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China; Harway Pharma Co., Ltd, Weifang, 262700, China.
Cancer letters
|January 24, 2025
概括
一种新型的双光动力疗法剂,Cy5-I-CF3,通过增强抗原呈现,有效诱导免疫细胞死亡 (ICD). 这种方法显示出对抗深层瘤的强有力的癌症免疫疗法的希望.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 免疫细胞死亡 (ICD) 对于抗癌疗法至关重要,但由于抗原呈现不佳,在深层瘤中面临挑战.
- 刺激强大的免疫反应需要有效的抗原呈现,这在晚期癌症中往往是不足的.
研究的目的:
- 开发一种高效的双光动态ICD诱导器,用于增强抗原呈现.
- 为了研究内细胞网膜 (ER) 和线粒体针对ICD诱导和免疫反应的协同效应.
主要方法:
- 开发具有增强反应性氧物种 (ROS) 生产的Cy5-I-CF3探头.
- 通过Cy5-I-CF3探针共同准癌细胞的ER和线粒体.
- 评估ROS诱导的ER压力,DAMP释放,ICD和随后的免疫细胞激活 (树突细胞和细胞毒性T淋巴细胞).
主要成果:
- Cy5-I-CF3表现出异常的ROS生成能力,导致协同的ER-线粒体相互作用和放大ER压力.
- 观察到与损伤相关的分子模式 (DAMPs) 的显著释放和强大的ICD诱导.
- 实现了增强的树突细胞成熟和细胞毒性T淋巴细胞透,促进了有效的免疫治疗.
结论:
- 双向的Cy5-I-CF3探针有效诱导ICD并增强内源抗原呈现,从而产生强大的光动力免疫疗法.
- 这种策略通过利用免疫系统,显著抑制初级和远程瘤的生长.
- 这些发现为设计新的ICD诱导剂提供了宝贵的见解,以推进癌症免疫治疗.
相关概念视频
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Psychoneuroimmunology: Diabetes and Cancer
22
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
22
Electron Transport Chain: Complex I and II
10.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.7K
Tumor Immunotherapy
467
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
467
The Extrinsic Apoptotic Pathway
6.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


